Bio-Rad Laboratories, Inc. (BIO) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bio-rad Laboratories, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.000 -- 00:00:04.820 Thank you for standing by. My name is Gil and I will be your operator for today's call. 00:00:04.820 -- 00:00:09.040 At this time, I would like to welcome each and everyone of you to the Bio-Rat Second 00:00:09.040 -- 00:00:13.160 Quarter 2025 results conference call and webcast. 00:00:13.160 -- 00:00:16.940 All lines will be placed in mute to prevent any background noise. 00:00:16.940 -- 00:00:20.660 After the speakers remarks, there will be a question and answer session. 00:00:20.660 -- 00:00:24.960 If you would like to ask a question during this time, simply press star followed by the 00:00:24.960 -- 00:00:29.200 number one on your telephone keypad. If you would like to read your question, simply 00:00:29.200 -- 00:00:34.240 press star one again. It is now my pleasure to turn today's call over to Bio-Rat's 00:00:34.240 -- 00:00:36.920 head of investor relations, Mr. Edward Trump. 00:00:36.920 -- 00:00:38.980 Please go ahead. 00:00:38.980 -- 00:00:42.080 Good afternoon, everyone. And thank you for joining us. 00:00:42.080 -- 00:00:46.920 Today, we will review the Second Quarter 2025 financial results and provide an update 00:00:46.920 -- 00:00:52.100 on key business trends for Bio-Rat. With me on the call today are Norman Schwartz, 00:00:52.100 -- 00:00:57.460 our chief executive officer, John DiVincenzo, president and chief operating officer, 00:00:57.460 -- 00:01:02.840 and Rupe Lacaraju, executive vice president and chief financial officer. 00:01:02.840 -- 00:01:06.960 Before we begin our review, I'd like to remind everyone that we will be making forward-looking 00:01:06.960 -- 00:01:12.000 statements about management's goals, plans and expectations, our future financial 00:01:12.000 -- 00:01:16.560 performance and other matte...